DIN 02443805 — CYRAMZA 10 MG
CYRAMZA is a solution of Ramucirumab marketed by ELI LILLY CANADA INC. The full Ramucirumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02443805
- Brand name
- CYRAMZA
- Active ingredient
- Ramucirumab
- Strength
- 10 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- ELI LILLY CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Antiangiogenic antineoplastic (VEGF Receptor 2 antagonist monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.